News | December 09, 2008

Given Imaging Pays $20 Million for Medtronics’s GERD Monitoring Business

December 9, 2008 - Given Imaging Ltd. has acquired the Bravo pH monitoring business for the diagnosis of Gastroesophageal Reflux Disease (GERD) from Medtronic for $20 million, strengthening Given Imaging’s gastrointestinal portfolio, which includes the a
video capsule platform.

The Bravo system, wireless, catheter-free pH test for GERD, uses a disposable capsule temporarily placed in the esophagus that measures pH levels and transmits the data to an external receiver.

pH testing is considered the gold standard for diagnosing GERD and during 2007 over 258,000 pH procedures were conducted in the U.S. Datamonitor estimates that around 147 million people in the U.S., Japan, France, Germany, Italy, Spain and the UK (around 20 percent of the population) suffer from GERD. The Bravo pH monitoring system is sold mainly in the US and to a lesser extent in Europe and is backed by strong reimbursement coverage in the US.

Under the terms of the agreement, Given Imaging will pay Medtronic $20 million. A small portion of the purchase price is contingent upon Medtronic completing the development of a new capsule delivery system already underway. During the first 12 months after the transaction closes, Medtronic will continue to supply the Bravo products to Given Imaging. During this 12-month period, Given Imaging intends to complete the transition of the Bravo system manufacturing operations to Israel. Given Imaging expects to incur a one-time charge of approximately $5 million in the fourth quarter of 2008 in connection with the acquisition.

Given Imaging technology platform is the PillCam Platform, featuring the PillCam
video capsule, a disposable, miniature video camera contained in a capsule, which is ingested by the patient, a sensor array, data recorder and RAPID software.

For more information: http://www.givenimaging.com

Related Content

Hologic Receives CE Mark for Three-in-One Omni Hysteroscope
News | Endoscopes | March 14, 2019
Hologic Inc. announced it has received a CE mark in Europe for its Omni hysteroscope, a three-in-one modular scope with...
Videos | Advanced Visualization | March 05, 2019
This is an example of a new endoscopic virtual peritoneal inflation tool on the patient's computed tomography (CT) im
Videos | Advanced Visualization | March 05, 2019
This is an example of a new endoscopic 3-D imaging simulator created from a patient's computed tomography (CT) scan u
Fujifilm Launches Latest Synapse 3D Version at HIMSS 2019

The new Intravoxel Incoherent Motion (IVIM) MR application in Synapse 3D

Technology | Advanced Visualization | February 08, 2019
Fujifilm Medical Systems U.S.A. will debut the latest version of its Synapse 3D solution at the Healthcare Information...
Body Vision Medical Announces Release of LungVision
Technology | Lung Cancer | October 05, 2018
Body Vision Medical, a medical device company specializing in lung cancer diagnostics, announced the launch of its...
American Society for Gastrointestinal Endoscopy and Touch Surgery Pilot Video-Based Endoscopic Simulations
News | Endoscopes | June 11, 2018
During the 2018 Digestive Disease Week (DDW) conference June 2-5 in Washington, D.C., the American Society for...
Olympus and Hitachi Healthcare Americas Introduce Arietta 850
News | Ultrasound Imaging | June 04, 2018
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedu
Body Vision Medical Receives FDA Clearance for LungVision Tool
Technology | Lung Cancer | May 09, 2018
Body Vision Medical received clearance from the U.S. Food and Drug Administration (FDA) to market their LungVision Tool...
El Camino Hospital Performs First U.S. Robotic Lung Cancer Bronchoscopy
News | Oncology Diagnostics | April 25, 2018
The interventional pulmonology team at the Taft Center for Clinical Research at El Camino Hospital in Mountain View,...
News | Endoscopes | April 02, 2018
Results from a recent prospective trial found the Wide Area Transepithelial Sampling with 3D Tissue Analysis (WATS3D)...